A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Assignment Study to Assess the Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation
Phase of Trial: Phase II/III
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs Reparixin (Primary)
- Indications Delayed graft function
- Focus Therapeutic Use
- Sponsors Dompe Spa
- 31 Aug 2018 Biomarkers information updated
- 12 Jun 2018 Status changed from active, no longer recruiting to completed.
- 13 Apr 2018 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.